← SynDRA
VARESPLADIB
SynDRA canonical compound SYN0004978 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | PLA2G2A |
| Mechanism of action | Secretory phospholipase inhibitor |
All known targets
Mechanisms of action (all sources)
- Secretory phospholipase inhibitor
- PLA2G2A INHIBITOR
- Phospholipase A2 group IIA inhibitor
Cross-references
Synonyms
- Varepladib
- Varespladib sodium
- LY-315920
- LY315920
- ((3-(AMINO(OXO)ACETYL)-1-BENZYL-2-ETHYL-1H-INDOL-4-YL)OXY)ACETIC ACID
- ((3-(Aminooxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yl)oxy)acetic acid
- ((3-(aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl)oxy)acetate
- ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy)acetic acid
- (3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-acetic acid
- (3-Aminooxalyl-1-benzyl-2-ethyl-2,3-dihydro-1H-indol-4-yloxy)-acetic acid
- 2-((3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yl)oxy)acetic acid
- 2-(1-benzyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetic acid
- 2-(3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yloxy)acetic acid
- 2-[[3-(2-Amino-2-oxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetic aci
- 2-[[3-(2-Amino-2-oxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetic acid
- 2-[2-ethyl-3-oxamoyl-1-(phenylmethyl)indol-4-yl]oxyethanoic acid
- 2-{[1-benzyl-3-(carbamoylcarbonyl)-2-ethyl-1H-indol-4-yl]oxy}acetic acid
- 2Q3P98DATH
- A-001
- A25228
- AC-32931
- ACETIC ACID, ((3-(AMINOOXOACETYL)-2-ETHYL-1-(PHENYLMETHYL)-1H-INDOL-4-YL)OXY)-
- Acetic acid, ((3-(aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl)oxy)-,
- AKOS015842901
- AMY19698
- AS-16956
- BCP01854
- BCP9000883
- BCPP000175
- BDBM50055366
- BRD-K09711437-001-01-9
- CCG-268404
- CHEBI:189668
- CHEMBL148674
- compound 6m [PMID: 8978844]
- D08107
- DB11909
- DTXSID50169378
- EN300-144829
Look up VARESPLADIB in the interactive SynDRA portal →